FDAnews — Information you need!
WEBFDAnews Webinar Training Pass. The FDAnews Webinar Training Pass program gives you year-round unrestricted access to any of the hundreds of webinars we run each year. These training programs feature top consultants, expert speakers and FDA officials. Keep track of global regulatory, legislative and business news developments in the industry.
WEBFeb 22, 2021 · The US Active Pharmaceutical Ingredient Infrastructure: The current state and considerations to increase US Healthcare Security “Keeping the Nation’s drug supply chain secure, robust, and resilient is essential for the national security and economic prosperity of the United States1.” I. Summary
FDA Launches New Webpage to Search for Documents on
WEBJan 9, 2024 · 212 Carnegie Center, Suite 301, Princeton, NJ 08540, USA. Phone 703.538.7600 – Toll free 888.838.5578
WEBSep 16, 2019 · FDA publishes these product-specific guidances to foster drug product development, and ANDA submission and approval, ultimately providing increased access to safe, affordable generic drugs. These guidances are published in an incremental manner and listed below in alphabetical order according to the active ingredient's name.
Novartis Restarts Production at Its Millburn, N.J. Facility
WEBJul 1, 2022 · Novartis said it has resumed operations at its Millburn, N.J., and Ivrea, Italy, plants after recently halting production over quality lapses related to the manufacture of radioligand therapy medicines. The Swiss drugmaker previously drew an FDA Form 483 following a fall 2021 inspection of its Millburn manufacturing site, when agency officials …
Judge Approves Pfizer’s $325 Million Settlement of ... - FDAnews
WEBNov 17, 2014 · A federal judge has finalized an agreement by Pfizer to pay $325 million to settle claims it marketed off-label uses of its epilepsy drug Neurontin. The decision ends a decade-old class-action lawsuit alleging Pfizer unit Warner-Lambert promoted Neurontin (gabapentin) for treatment of migraine headaches, depression and as a painkiller. None …
WEBMay 25, 2021 · Emergency Use Authorization for Vaccines to Prevent COVID-19 Guidance for Industry. Document issued on May 25, 2021. This document supersedes the guidance of the same title issued on February 22, 2021 and October 2020. U.S. Department of Health and Human Services. Food and Drug Administration.
Good Documentation: More Than Entering Data | 2014-08-13
WEBAug 13, 2014 · Good Documentation Practices are guided by five standards. These standards consist of truth, accuracy, completeness, legibility, and timeliness. Truth: This standard maintains that the person who completed the process or performed the task actually did the work—and completed the appropriate documentation. No signature …
Abbott's Amplatzer Amulet Device Gains FDA Approval for Atrial ...
WEBAugust 19, 2021. Abbott has received the FDA’s approval for its Amplatzer Amulet left atrial appendage occluder for treatment of individuals with atrial fibrillation (AFib) at risk of ischemic stroke. The amulet immediately closes the patient’s left atrial appendage — an area where blood clots can form in patients with AFib — reducing ...
WEBJurisdiction defined by the Federal Food, and Cosmetic Act (FDCA) and the Health Service Act. Human food, including dietary supplements and color additives and OTC medications, and APIs Vaccines, blood products, and biologics Medical devices Radiation-emitting products Cosmetics Animal food, feed, and veterinary medicines Tobacco products.
Skip to content